Skip to content

AMERICAN ORIENTAL BIOENGINEERING INC: 10-Q filed 2014-01-30

What AMERICAN ORIENTAL BIOENGINEERING INC reported in its quarterly report filed 2014-01-30 (fiscal Q3 2013): 51 published measures, 138 facts as tagged in accession 0001019687-14-000311.

This filing

Form
10-Q (quarterly report)
Filed
2014-01-30
Fiscal period
fiscal Q3 2013
Accession
0001019687-14-000311 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AMERICAN ORIENTAL BIOENGINEERING INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-30427,624,938USD
At 2012-12-31446,308,924USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-30143,948,688USD
At 2012-12-31118,722,218USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-30283,676,250USD
At 2012-12-31327,586,706USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-303,230,995USD
At 2012-12-317,097,098USD
At 2012-09-3026,432,161USD
At 2011-12-3152,627,928USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-21,176,605USD92
2013-01-01 to 2013-09-30-55,132,361USD273
2012-07-01 to 2012-09-3019,117,451USD92
2012-01-01 to 2012-09-30-23,826,671USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-21,926,697USD273
2012-01-01 to 2012-09-30-37,139,732USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-3015,119,941USD273
2012-01-01 to 2012-09-309,347,876USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-07-01 to 2013-09-3017,936,408USD92
2013-01-01 to 2013-09-3059,167,308USD273
2012-07-01 to 2012-09-3029,493,459USD92
2012-01-01 to 2012-09-3082,685,661USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-09-3027,068,568USD273
2012-01-01 to 2012-09-30-16,443,390USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-10,676,223USD273
2012-01-01 to 2012-09-3025,807,373USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-3022,965,362USD
At 2012-12-3178,097,723USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-07-01 to 2013-09-3036,539,591shares92
2013-01-01 to 2013-09-3036,559,336shares273
2012-07-01 to 2012-09-3037,403,519shares92
2012-01-01 to 2012-09-3038,722,635shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-07-01 to 2013-09-3036,539,591shares92
2013-01-01 to 2013-09-3036,559,336shares273
2012-07-01 to 2012-09-3038,287,158shares92
2012-01-01 to 2012-09-3038,722,635shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-0.58USD/shares92
2013-01-01 to 2013-09-30-1.51USD/shares273
2012-07-01 to 2012-09-300.51USD/shares92
2012-01-01 to 2012-09-30-0.62USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-0.58USD/shares92
2013-01-01 to 2013-09-30-1.51USD/shares273
2012-07-01 to 2012-09-300.5USD/shares92
2012-01-01 to 2012-09-30-0.62USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-07-01 to 2013-09-30258,611USD92
2013-01-01 to 2013-09-301,308,937USD273
2012-07-01 to 2012-09-30487,280USD92
2012-01-01 to 2012-09-301,441,245USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-30186,221,818USD
At 2012-12-31171,381,389USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-09-301,186,343USD273
2012-01-01 to 2012-09-301,946,902USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-18,972,997USD92
2013-01-01 to 2013-09-30-48,310,885USD273
2012-07-01 to 2012-09-30-19,196,919USD92
2012-01-01 to 2012-09-30-56,506,400USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-3064,777,035USD
At 2012-12-3195,448,481USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-09-302,056,262USD273
2012-01-01 to 2012-09-304,253,127USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-30126,313,850USD
At 2012-12-31106,211,564USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-307,380,644USD
At 2012-12-3111,005,423USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-09-3011,791,161USD
At 2012-12-3113,116,380USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-3027,228,043USD
At 2012-12-3145,543,611USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2013-01-01 to 2013-09-300USD273
2012-01-01 to 2012-09-301,270,603USD274

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-3022,080,897USD92
2013-01-01 to 2013-09-3060,905,594USD273
2012-07-01 to 2012-09-3025,653,281USD92
2012-01-01 to 2012-09-3073,836,830USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-09-3020,518,004USD
At 2012-12-3120,570,846USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-303,107,900USD92
2013-01-01 to 2013-09-3012,594,709USD273
2012-07-01 to 2012-09-306,456,362USD92
2012-01-01 to 2012-09-3017,330,430USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-07-01 to 2013-09-3014,828,508USD92
2013-01-01 to 2013-09-3046,572,599USD273
2012-07-01 to 2012-09-3023,037,097USD92
2012-01-01 to 2012-09-3065,355,231USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-07-01 to 2013-09-309,497,545USD92
2013-01-01 to 2013-09-3032,992,571USD273
2012-07-01 to 2012-09-3012,005,502USD92
2012-01-01 to 2012-09-3036,047,706USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-303,245,188USD92
2013-01-01 to 2013-09-306,374,904USD273
2012-07-01 to 2012-09-301,681,649USD92
2012-01-01 to 2012-09-304,977,883USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3036,566,765shares
At 2012-12-3136,419,706shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-30178,447,391USD
At 2012-12-31177,974,127USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-09-3081,713,019USD
At 2012-12-3171,789,958USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-09-305,122,549USD
At 2012-12-31619,401USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-09-30214,417,207USD
At 2012-12-31208,786,773USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-09-3043,320,812USD
At 2012-12-3137,405,384USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-09-30146,621,019USD
At 2012-12-31145,314,928USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-3018,883,588USD
At 2012-12-3116,339,129USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-09-309,328,021USD
At 2012-12-3110,292,360USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-20,917,994USD92
2013-01-01 to 2013-09-30-53,823,424USD273
2012-07-01 to 2012-09-3019,620,051USD92
2012-01-01 to 2012-09-30-22,381,008USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-21,176,605USD92
2013-01-01 to 2013-09-30-55,132,361USD273
2012-07-01 to 2012-09-3019,132,771USD92
2012-01-01 to 2012-09-30-23,822,253USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-18,636,863USD92
2013-01-01 to 2013-09-30-45,209,300USD273
2012-07-01 to 2012-09-3018,447,733USD92
2012-01-01 to 2012-09-30-20,509,053USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-09-304,872,085USD273
2012-01-01 to 2012-09-305,095,598USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-09-309,085,884USD273
2012-01-01 to 2012-09-308,955,563USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-41,207USD92
2013-01-01 to 2013-09-30130,622USD273
2012-07-01 to 2012-09-3094,724USD92
2012-01-01 to 2012-09-30443,473USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-01-01 to 2013-09-30617,080USD273
2012-01-01 to 2012-09-3064,435USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-3017,820,040USD273
2012-01-01 to 2012-09-309,251,412USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30289,282USD273
2012-01-01 to 2012-09-308,376,013USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-3,657,087USD273
2012-01-01 to 2012-09-301,978,576USD274

Inspect the source

Entity
AMERICAN ORIENTAL BIOENGINEERING INC / CIK 0001090514
Captured
SEC response SHA-256
d27e0b0ae19f35fdd055db9335f4763b7c7596c669714d715acd3e36b540c54a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001090514.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))